Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Matson JA, Bush JA. Sandramycin, a novel antitumor antibiotic produced by a Nocardioides sp. Production, isolation, characterization and biological properties. J. Antibiot. 42: 1763-1767, 1989. PubMed: 2621159
Matson JA, Bush JA. Antitumor antibiotic compound. US Patent 4,582,639 dated Apr 15 1986
Matson JA, et al. Sandramycin, a novel antitumor antibiotic produced by a Nocardioides sp. II. Structure determination. J. Antibiot. 46: 162-166, 1993. PubMed: 8436549
Park YH, et al. Classification of 'Nocardioides fulvus' IFO 14399 and Nocardioides sp. ATCC 39419 in Kribbella gen. nov., as Kribbella flavida sp. nov. and Kribbella sandramycini sp. nov.. Int. J. Syst. Bacteriol. 49: 743-752, 1999. PubMed: 10319498
type strain
type strain
Nucleotide (GenBank) : AF005020 Nocardioides sp. ATCC 39419 16S ribosomal RNA gene, partial sequence.
Nucleotide (GenBank) : AF110046 Nocardioides sp. ATCC 39419 ribonuclease P RNA gene, partial sequence.
Nucleotide (GenBank) : AF017504 Nocardioides sp. ATCC 39419 16S-23S internal transcribed spacer, complete sequence.
Nucleotide (GenBank) : AF017505 Nocardioides sp. ATCC 39419 16S-23S internal transcribed spacer, complete sequence.
